Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Oxycodone/naloxone prolonged release tablets
DRUG
2 trials
Sponsors
Mundipharma Research GmbH & Co KG
, Mundipharma (China) Pharmaceutical Co. Ltd
Conditions
Non Cancer Pain
Parkinson's Disease With Severe Pain
Phase 3
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
Completed
NCT01439100
Mundipharma Research GmbH & Co KG
Parkinson's Disease With Severe Pain
Start: 2011-10-31
End: 2013-10-31
Target: 172
Updated: 2014-02-06
Targin for Non-cancer Pain
Completed
NCT01918098
Mundipharma (China) Pharmaceutical Co. Ltd
Non Cancer Pain
Start: 2013-09-01
End: 2017-03-30
Updated: 2017-11-14
Related Papers
Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial.
2020-02-03
2 citations
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.
2015-10-19
89 citations